Literature DB >> 24949559

Comparison of QoL-AD and DQoL in elderly with Alzheimer's disease.

Aurore Wolak-Thierry1, Jean-Luc Novella, Coralie Barbe, Isabella Morrone, Rachid Mahmoudi, Damien Jolly.   

Abstract

OBJECTIVE: The Dementia Quality of Life (DQoL) and the Quality of Life in Alzheimer's Disease (QoL-AD) are the two most widely used dementia-specific QoL instruments in the world. We aimed to compare the psychometric properties of these two instruments and identify which is most adapted to use in geriatric consultations.
METHODS: To evaluate the psychometric properties of the French language validation of DQoL and QoL-AD, 123 patients aged 65 years and over suffering from AD (Mini Mental State Examination score ≥10) were recruited in seven French hospitals and one Switzerland hospital. The DQoL comprises 29 items, ranked on a five-point Likert scale and measuring five QoL domains: self-esteem, positive affect, negative affect, feeling of belonging and sense of aesthetics. The QoL-AD contains 13 items giving an overall score ranging from 13 to 52 and evaluating the domains of interpersonal relationships, financial difficulties, physical condition, memory, mood and overall health.
RESULTS: Both questionnaires showed adequate reproducibility at 2 weeks interval (intra-class correlation coefficient >0.80), good internal consistency (Cronbach's alpha coefficient >0.70) and good convergent validity with the general health dimension of the Duke Health Profile. The time required to complete the QoL-AD was significantly shorter (p < 0.0001). DQoL had better discriminant capacity (with at least one dimension significant for each subgroup of severity of cognitive decline, dependency, presence of depression or behavioural disorders).
CONCLUSIONS: For quick evaluation of QoL during consultations in geriatric care, the QoL-AD is preferable, whereas for the purposes of research and more in-depth evaluation, the DQoL is more suitable.

Entities:  

Keywords:  DQoL; QoL-AD; comparison

Mesh:

Year:  2014        PMID: 24949559     DOI: 10.1080/13607863.2014.927822

Source DB:  PubMed          Journal:  Aging Ment Health        ISSN: 1360-7863            Impact factor:   3.658


  4 in total

1.  Transcranial direct current stimulation for depression in Alzheimer's disease: study protocol for a randomized controlled trial.

Authors:  Zui Narita; Yuma Yokoi
Journal:  Trials       Date:  2017-06-19       Impact factor: 2.279

2.  Supporting caregivers of veterans with Alzheimer's disease and traumatic brain injury: study protocol for a randomized controlled trial.

Authors:  Jennifer L Carnahan; Katherine S Judge; Joanne K Daggy; James E Slaven; Nicki Coleman; Emily L Fortier; Christopher Suelzer; Nicole R Fowler
Journal:  Trials       Date:  2020-04-19       Impact factor: 2.279

3.  The efficacy of exergaming in people with major neurocognitive disorder residing in long-term care facilities: a pilot randomized controlled trial.

Authors:  Nathalie Swinnen; Mathieu Vandenbulcke; Eling D de Bruin; Riekje Akkerman; Brendon Stubbs; Joseph Firth; Davy Vancampfort
Journal:  Alzheimers Res Ther       Date:  2021-03-30       Impact factor: 6.982

4.  The MOMANT study, a caregiver support programme with activities at home for people with dementia: a study protocol of a randomised controlled trial.

Authors:  S C E Balvert; M V Milders; J E Bosmans; M W Heymans; S van Bommel; R-M Dröes; E J A Scherder
Journal:  BMC Geriatr       Date:  2022-04-07       Impact factor: 3.921

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.